🇺🇸 FDA
Patent

US 8722732

Oligomer-calcimimetic conjugates and related compounds

granted A61KA61K47/60A61P

Quick answer

US patent 8722732 (Oligomer-calcimimetic conjugates and related compounds) held by Nektar Therapeutics expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K47/60, A61P, A61P5/10, A61P5/20